Tobacco cessation pharmacotherapy
Phase 3Small molecule
Tobacco cessation pharmacotherapy is one of 4 small molecule programs targeting Tobacco Use. It is currently in Phase 3.
1
Indications
1
Total Trials
1
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
4 competitors in Tobacco Use
#DrugCompanyPhaseTrials
1Nicotine Free Cigarettes
PfizerPhase 3
Tobacco cessation pharmacotherapy
IIowa City Veterans Affairs Medical Center
Phase 3
SPECTRUM Cigarettes
WWake Forest University Health Sciences
Phase 1
Menthol
GSKPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details